We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+17.52%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$11.2B
AUM Growth
+$880M
Cap. Flow
-$410M
Cap. Flow %
-3.65%
Top 10 Hldgs %
52.23%
Holding
59
New
9
Increased
20
Reduced
12
Closed
14
Avg Time Held Equity + Options
9.2 quarters
Top 10 Avg Time Held Equity + Options
4 quarters
Top 20 Avg Time Held Equity + Options
6.6 quarters
Avg Time Held Equity only
9.2 quarters
Top 10 Avg Time Held Equity only
4 quarters
Top 20 Avg Time Held Equity only
6.6 quarters

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$525M
2
HUM icon
Humana
HUM
+$325M
3
CI icon
Cigna
CI
+$303M
4
LYB icon
LyondellBasell Industries
LYB
+$286M
5
NXPI icon
NXP Semiconductors
NXPI
+$188M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$794M
2
CVS icon
CVS Health
CVS
+$556M
3
DD icon
DuPont de Nemours
DD
+$461M
4
FDC
First Data Corporation
FDC
+$267M
5
EBAY icon
eBay
EBAY
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 53.05%
2 Technology 14.26%
3 Materials 12.73%
4 Communication Services 9.13%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DXC icon
1
DXC Technology
DXC
$2.04B
$707M 6.31%
10,994,368
+1,780,732
+19% +$114M
2017 Q2
7 quarters
FMC icon
2
FMC
FMC
$1.29B
$704M 6.28%
9,167,262
-1,109,259
-11% -$81.4M
2015 Q1
16 quarters
CI icon
3
Cigna
CI
$74.7B
$704M 6.28%
4,376,891
+1,658,305
+61% +$303M
2013 Q2
23 quarters
MCK icon
4
McKesson
MCK
$112B
$576M 5.14%
4,918,907
+398,021
+9% +$49.1M
2016 Q4
9 quarters
IQV icon
5
IQVIA
IQV
$42.9B
$563M 5.02%
3,910,507
-1,452,425
-27% -$194M
2016 Q2
11 quarters
HCA icon
6
HCA Healthcare
HCA
$99.8B
$553M 4.94%
4,243,504
-655,065
-13% -$88M
2013 Q2
23 quarters
TAK icon
7
Takeda Pharmaceutical
TAK
$59.2B
$532M 4.75%
+26,112,660
New +$525M
2019 Q1
0 quarters
HOLX icon
8
DELISTED
Hologic
HOLX
$521M 4.65%
10,758,550
+844,507
+9% +$38.1M
2018 Q2
3 quarters
THC icon
9
Tenet Healthcare
THC
$21.5B
$516M 4.61%
17,900,928
+5,614
+0% +$139K
2013 Q2
23 quarters
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.33T
$478M 4.26%
8,119,760
-801,260
-9% -$45.2M
2015 Q4
13 quarters
FDC
11
DELISTED
First Data Corporation
FDC
$382M 3.41%
14,553,631
-11,223,562
-44% -$267M
2016 Q2
11 quarters
LYB icon
12
LyondellBasell Industries
LYB
$19.4B
$361M 3.22%
4,291,569
+3,312,724
+338% +$286M
2018 Q3
2 quarters
HUM icon
13
Humana
HUM
$50.5B
$349M 3.11%
1,312,039
+1,126,844
+608% +$325M
2018 Q4
1 quarter
ELV icon
14
Elevance Health
ELV
$92.2B
$292M 2.61%
1,018,237
+145,804
+17% +$42.2M
2014 Q1
20 quarters
NXPI icon
15
NXP Semiconductors
NXPI
$57.1B
$286M 2.55%
3,238,670
+2,141,625
+195% +$188M
2018 Q3
2 quarters
UHS icon
16
Universal Health Services
UHS
$10.6B
$275M 2.46%
2,058,124
+95,577
+5% +$12.6M
2016 Q3
10 quarters
TMO icon
17
Thermo Fisher Scientific
TMO
$245B
$268M 2.4%
980,589
-196,252
-17% -$48.8M
2013 Q2
23 quarters
BHC icon
18
Bausch Health
BHC
$2.2B
$230M 2.05%
9,315,244
+2,724,936
+41% +$65.1M
2018 Q3
2 quarters
MSFT icon
19
Microsoft
MSFT
$4.04T
$224M 2%
1,902,131
+649,380
+52% +$70.8M
2018 Q2
3 quarters
WMB icon
20
Williams Companies
WMB
$91.2B
$215M 1.92%
7,488,701
-1,324,432
-15% -$35.5M
2016 Q2
11 quarters
FLEX icon
21
Flex
FLEX
$41B
$205M 1.83%
27,261,688
+6,470,804
+31% +$46.3M
2013 Q2
23 quarters
PARA icon
22
DELISTED
Paramount Global Class B
PARA
$196M 1.75%
4,129,237
+43,486
+1% +$2.12M
2013 Q2
23 quarters
COR icon
23
Cencora
COR
$63B
$173M 1.55%
2,180,396
+2,004,048
+1,136% +$161M
2018 Q1
4 quarters
MTOR
24
DELISTED
MERITOR, Inc.
MTOR
$157M 1.4%
7,699,201
-600,000
-7% -$12.2M
2013 Q2
23 quarters
NVT icon
25
nVent Electric
NVT
$26.1B
$151M 1.34%
5,579,650
-1,077,447
-16% -$27.6M
2018 Q2
3 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Glenview Capital Management held 59 positions worth $11.2B, up 8.5% from $10.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Glenview Capital Management withdrew a net $410M in Q1 2019, closing 14 positions and reducing 12 holdings. Its most notable exit was Shire pic, an estimated $794M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 53% a quarter earlier, followed by Technology and Materials.

Against the trend, Glenview Capital Management opened a new position in Takeda Pharmaceutical worth $532M.

  • Glenview Capital Management's largest Q1 2019 buy was Takeda Pharmaceutical: 26,112,660 shares worth $532M.
  • Glenview Capital Management added most to Humana in Q1 2019, an estimated $325M increase.
  • Glenview Capital Management's biggest Q1 2019 reduction was First Data Corporation, cutting an estimated $267M.
  • Glenview Capital Management fully exited Shire pic in Q1 2019, selling an estimated $794M.
  • Glenview Capital Management's ten largest holdings make up 52% of its $11.2B portfolio in Q1 2019.
  • Glenview Capital Management opened 9 new positions and closed 14 in Q1 2019.
  • Glenview Capital Management's portfolio value rose 8.5% quarter-over-quarter to $11.2B.

Based on Glenview Capital Management's 13F filing for Q1 2019, filed 15 May 2019.